[1]黄玲玉,孙 东,蒋本君,等.天津市某区域体检人群非酒精性脂肪肝调查分析[J].医学信息,2019,32(04):99-103.[doi:10.3969/j.issn.1006-1959.2019.04.032]
 HUANG Ling-yu,SUN Dong,JIANG Ben-jun,et al.Investigation and Analysis of Non-alcoholic Fatty Liver Disease in Medical Examination Population in A Certain Area of Tianjin[J].Journal of Medical Information,2019,32(04):99-103.[doi:10.3969/j.issn.1006-1959.2019.04.032]
点击复制

天津市某区域体检人群非酒精性脂肪肝调查分析()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年04期
页码:
99-103
栏目:
论著
出版日期:
2019-02-15

文章信息/Info

Title:
Investigation and Analysis of Non-alcoholic Fatty Liver Disease in Medical Examination Population in A Certain Area of Tianjin
文章编号:
1006-1959(2019)04-0099-05
作者:
黄玲玉1孙 东2蒋本君3王 敏3张燕杰4
(1.天津市胸科医院/南开大学附属胸科医院科教科,天津 300222;2.天津医科大学一中心临床学院,天津 300000;3.天津市胸科医院体检中心,天津 300222;4.天津市胸科医院院长办公室,天津 300222)
Author(s):
HUANG Ling-yu1SUN Dong2JIANG Ben-jun3WANG Min3ZHANG Yan-jie4
(1.Department of Science and Education,Tianjin chest Hospital/Nankai University,Tianjin 300222,China;2. One Center Clinical Medical College,Tianjin Medical University,Tianjin 300000,China;3. Physical Examination Center,Tianjin Chest Hospital,Tianjin 3002
关键词:
非酒精性脂肪性肝病流行病学高危因素患病率谷丙转氨酶
Keywords:
Non-alcoholic fatty liver diseaseEpidemiologyHigh risk factorsCase rateAlanine aminotransferase
分类号:
R188.2
DOI:
10.3969/j.issn.1006-1959.2019.04.032
文献标志码:
A
摘要:
目的 探索天津市某区域体检人群非酒精性脂肪肝的患病率现状及相关危险因素。方法 选取我院 2016年1月~2017年10月7528名参加体检人群为研究对象,统计NAFLD的检出率,分析各行为因素及实验室指标与NAFLD的相关性。结果 根据筛选标准,共有3256人纳入本研究,检出NAFLD计952例(29.24%);NAFLD与性别、作息习惯、饮食习惯、运动量、吸烟史、少量饮酒史及职业性质有关(P均<0.05);NAFLD患者更易伴有肥胖及高血压;NAFLD患者URIC[(287.10±42.15)μmol/L vs (226.89±39.61)μmol/L)]、FBG[(5.66±1.81)mmol/L vs (4.32±1.21)mmol/L]、LDL[(2.83±0.53)mmol/L vs (2.34±0.48)mmol/L]、VLDL[(0.45±0.12)mmol/L vs (0.33±0.08)mmol/L]、TC[(4.59±1.28)mmol/L vs (3.48±0.84)mmol/L)]、TG[(1.81±0.39)mmol/L vs (1.28±0.36)mmol/L)]高于非NAFLD体检者,且HDL[(1.32±0.27)mmol/L vs (1.64±0.32)mmol/L)]减低,差异均具有统计学意义(P均<0.05)。NALFD体检者更易检出水平异常增高的ALT及FBG(P均<0.05)。结论 天津市某区域体检人群NAFLD患病率约29.24%,男性、作息不规律、油腻饮食、低运动量、有吸烟史、少量饮酒史、内勤职业为NAFLD的高危因素,更易伴有尿酸、空腹血糖、低密度脂蛋白、极低密度脂蛋白、胆固醇、甘油三酯、谷丙转氨酶的升高及高密度脂蛋白的降低。具有上述高危因素的人群应尽早诊治。
Abstract:
Objective To investigate the prevalence of non-alcoholic fatty liver disease and related risk factors in a regional medical examination population in Tianjin. Methods A total of 7528 participants from January 2016 to October 2017 were enrolled in the study. The detection rate of NAFLD was statistically analyzed, and the correlation between various behavioral factors and laboratory indicators and NAFLD was analyzed. Results According to the screening criteria, a total of 3,256 people were included in the study, and 952 cases (29.24%) of NAFLD were detected. NAFLD was related to gender, work habits, eating habits, exercise volume, smoking history, small drinking history and occupational nature (P<0.05). Patients with NAFLD are more likely to be associated with obesity and hypertension;Patients with NAFLD had a URIC [(287.10±42.15) μmol/L vs (226.89±39.61) μmol/L), FBG [(5.66±1.81) mmol/L vs (4.32±1.21) mmol/L], LDL [(2.83±) 0.53) mmol/L vs (2.34±0.48) mmol/L], VLDL [(0.45±0.12) mmol/L vs (0.33±0.08) mmol/L], TC[(4.59±1.28) mmol/L vs (3.48 ±0.84)mmol/L)], TG[(1.81±0.39) mmol/L vs (1.28±0.36 mmol/L)] was higher than non-NAFLD biopsy, and HDL [(1.32±0.27) mmol/L vs ( 1.64±0.32)mmol/L)] decreased, the difference was statistically significant (P<0.05). NALFD patients were more likely to detect abnormally elevated levels of ALT and FBG (P<0.05). Conclusion The prevalence of NAFLD in a certain physical examination population in Tianjin is about 29.24%. Men, irregular work schedule, greasy diet, low exercise volume, smoking history, a small amount of drinking history, and high-risk factors of NAFLD are more likely to be accompanied by uric acid and fasting blood glucose. , low density lipoprotein, very low density lipoprotein, cholesterol, triglycerides, alanine aminotransferase and high density lipoprotein reduction. People with the above-mentioned high risk factors should be treated as soon as possible.

参考文献/References:


[1]Alexander M,Loomis AK,Fairburn-Beech J,et al.Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease[J].BMC Med,2018,16(1):130.
[2]田涛.探究中西医结合治疗非酒精性脂肪肝病的临床价值[J].医学信息,2018,31(z1):192-193.
[3]中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南(2018年更新版)[J].实用肝脏病杂志,2018,21(2):177-186.
[4]Chalasani N,Younossi Z,Lavine JE,et al.The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases[J].Hepatology,2018,67(1):328-357.
[5]孟昱林,张海艳,宋宝国,等.唐山市体检人群脂肪肝患病率调查分析[J].临床肝胆病杂志,2017,33(12):2376-2380.
[6]韩秀娟.脂肪肝患病率及相关因素的调查分析[J].继续医学教育,2016,30(3):75-76.
[7]丁蕾,陈婧鑫,左翔,等.芜湖市社区居民脂肪肝患病现状及影响因素分析[J].中华疾病控制杂志,2017,21(6):635-637.
[8]丁芳,秦雨萌,曹群英,等.咸宁市健康体检人群非酒精性脂肪肝病的分布特征及危险因素分析[J].护理研究,2017,31(4):490-492.
[9]王小瑞,王晓荣,郭春林,等.包头市体检人群脂肪肝的患病率及危险因素调查分析[J].现代消化及介入诊疗,2015,20(3):239-242.
[10]井永法,王朝阳,陈玲玲,等.冀南地区脂肪肝患病率及危险因素的流行病学调查[J].河北医药,2015,37(7):1088-1090.
[11]Hart-Unger S,Arao Y,Hamilton KJ,et al.Hormone signaling and fatty liver in females: analysis of estrogen receptor α mutant mice[J].Int J Obes (Lond),2017,41(6):945-954.
[12]陈贱兰,陈前萍,曾顺生.非酒精性脂肪肝患者肝功能酶学指标与血脂检测结果相关性研究[J].医学信息,2017,30(15):185-186.

相似文献/References:

[1]李 淼,孙浩淼,纵书芳,等.徐州地区2015~2016年手足口病流行病学特征分析[J].医学信息,2018,31(02):77.[doi:10.3969/j.issn.1006-1959.2018.02.026]
 LI Miao,SUN Hao-miao,ZONG Shu-fang,et al.Epidemiological Characteristics of Hand-foot-mouth Disease in Xuzhou Area in 2015 to 2016[J].Journal of Medical Information,2018,31(04):77.[doi:10.3969/j.issn.1006-1959.2018.02.026]
[2]龙 颖,李运泽,汤中敏,等.非酒精性脂肪性肝病与血尿酸水平测定及其临床意义[J].医学信息,2018,31(07):92.[doi:10.3969/j.issn.1006-1959.2018.07.029]
 LONG Ying,LI Yun-ze,TANG Zhong-min,et al.Determination of Serum Uric Acid Level and its Clinical Significance in Non-alcoholic Fatty Liver Disease[J].Journal of Medical Information,2018,31(04):92.[doi:10.3969/j.issn.1006-1959.2018.07.029]
[3]徐 伦.2010-2020年大连金普新区肺结核流行病学调查分析[J].医学信息,2022,35(09):14.[doi:10.3969/j.issn.1006-1959.2022.09.004]
 XU Lun.Epidemiological Survey of Pulmonary Tuberculosis in Jinpu New District of Dalian from 2010 to 2020[J].Journal of Medical Information,2022,35(04):14.[doi:10.3969/j.issn.1006-1959.2022.09.004]
[4]崔姗姗,刘 英,江 霞.非酒精性脂肪性肝病与胰岛素抵抗的研究进展[J].医学信息,2022,35(10):66.[doi:10.3969/j.issn.1006-1959.2022.10.016]
 CUI Shan-shan,LIU Ying,JIANG Xia.Research Progress on Non-alcoholic Fatty Liver Disease and Insulin Resistance[J].Journal of Medical Information,2022,35(04):66.[doi:10.3969/j.issn.1006-1959.2022.10.016]
[5]冯贺强,张彩红.肠道菌群与非酒精性脂肪肝关系的研究进展[J].医学信息,2018,31(12):47.[doi:10.3969/j.issn.1006-1959.2018.12.015]
 FENG He-qiang,ZHANG Cai-hong.Research Progress on the Relationship between Intestinal Flora and Nonalcoholic Fatty Liver[J].Journal of Medical Information,2018,31(04):47.[doi:10.3969/j.issn.1006-1959.2018.12.015]
[6]孙惠昕,贾海晗,王婉莹,等.胰腺癌流行现状和影响因素的研究[J].医学信息,2022,35(11):47.[doi:10.3969/j.issn.1006-1959.2022.11.014]
 SUN Hui-xin,JIA Hai-han,WANG Wan-ying,et al.The Prevalence and Influencing Factors of Pancreatic Cancer[J].Journal of Medical Information,2022,35(04):47.[doi:10.3969/j.issn.1006-1959.2022.11.014]
[7]郑 颖,孙华胜,毛乾国.中医防治非酒精性脂肪性肝病研究进展[J].医学信息,2018,31(15):25.[doi:10.3969/j.issn.1006-1959.2018.15.010]
 ZHENG Ying,SUN Hua-sheng,MAO Qian-guo.Progress in Prevention and Treatment of Nonalcoholic Fatty Liver Disease by TCM[J].Journal of Medical Information,2018,31(04):25.[doi:10.3969/j.issn.1006-1959.2018.15.010]
[8]阿不都热依木·阿不都克力木,陈 薇,高 枫,等.乌鲁木齐市2012年~2017年其他感染性腹泻流行特征分析[J].医学信息,2018,31(18):104.[doi:10.3969/j.issn.1006-1959.2018.18.032]
 Abdureyim·abdukeyim,CHEN Wei,GAO Feng,et al.Epidemiological Characteristics of Other Infectious Diarrhea in Urumqi City from 2012 to 2017[J].Journal of Medical Information,2018,31(04):104.[doi:10.3969/j.issn.1006-1959.2018.18.032]
[9]李立康,许琼军,杨日飞,等.2012年~2016年三亚市生殖器疱疹流行病学分析[J].医学信息,2018,31(20):102.[doi:10.3969/j.issn.1006-1959.2018.20.030]
 LI Li-kang,XU Qiong-jun,YANG Ri-fei,et al.Epidemiological Analysis of Genital Herpes in Sanya City from 2012 to 2016[J].Journal of Medical Information,2018,31(04):102.[doi:10.3969/j.issn.1006-1959.2018.20.030]
[10]李珊珊,陈少彬,龚先琼.中药单体治疗非酒精性脂肪性肝病研究进展[J].医学信息,2018,31(21):24.[doi:10.3969/j.issn.1006-1959.2018.21.008]
 LI Shan-shan,CHEN Shao-bin,GONG Xian-qiong.Advances in Research of Traditional Chinese Medicine Monomer in the Treatment of Non-alcoholic Fatty Liver Disease[J].Journal of Medical Information,2018,31(04):24.[doi:10.3969/j.issn.1006-1959.2018.21.008]

更新日期/Last Update: 2019-03-07